The Democratic Republic of Congo has been allocated 70,000 doses of Merck's (MRK.N), opens new tab Ervebo vaccine for Ebola, the World Health Organization said on Thursday, as the country...

WHO experts say early evidence, including animal studies, suggests Ervebo could offer some protection—and the new trial will seek to establish whether that protection extends to…

Imunizante aprovado mira a cepa Zaire, não a Bundibugyo

But it's not known if it will protect against the virus responsible for the current outbreak